Serb SA

Serb SA develops and supplies pharmaceuticals for critical care and rare diseases. The Company produces antidotes, including CBRN countermeasures, and distributes medicines to healthcare professionals and systems. Serb SA serves healthcare professionals, systems, and governments in France, the United States, and Belgium.